Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 1217-1229

  Zheng, Zhong ^a   Cummings, Richard D ^b   Pummill, Philip E ^b   Kincade, Paul W ^a,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Blood glucose; Cell adhesion; Extracellular matrix; Glycosylation; Tumors

Indexed keywords

GLUCOSE; HERMES ANTIGEN; HYALURONIC ACID; SIALIDASE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL GROWTH; CHO CELL; CONTROLLED STUDY; GLYCOSYLATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0030930218     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119635     Document Type: Article

References (75)

1. Zimmermann, D.R., and E. Ruoslahti. 1989. Multiple domains of the large fibroblast proteoglycan, versican. EMBO (Eur. Mol. Biol. Organ.) J. 8: 2975-2981.
2. Rauch, U., P. Gao, A. Janetzko, A. Flaccus, L. Hilgenberg, H. Tekotte, R.K. Margolis, and R.U. Margolis. 1991. Isolation and characterization of developmentally regulated chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of brain identified with monoclonal antibodies. J. Biol. Chem. 266:14785-14801.
3. Doege, K.J., M. Sasaki, T. Kimura, and Y. Yamada. 1991. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. J. Biol. Chem. 266:894-902.
4. Yamada, H., K. Watanabe, M. Shimonaka, and Y. Yamaguchi. 1994. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J. Biol. Chem. 269:10119-10126.
5. Deak, F., I. Kiss, K.J. Sparks, W.S. Argraves, G. Hampikian, and P.F. Goetinck. 1986. Complete amino acid sequence of chicken cartilage link protein deduced from cDNA clones. Proc. Natl. Acad. Sci. USA. 83:3766-3770.
6. Perides, G., W.S. Lane, D. Andrews, D. Dahl, and A. Bignami. 1989. Isolation and partial characterization of a glial hyaluronate-binding protein. J. Biol. Chem. 264:5981-5987.
7. Lee, T.H., H. Wisniewski, and J. Vilcek. 1992. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell Biol. 116:545-557.
8. Toole, B.P. 1990. Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol. 2:839-844.
9. Knudson, C.B., and W. Knudson. 1993. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB (Fed. Am. Soc. Exp. Biol.) J. 7:1233-1241.
10. Lesley, J., R. Hyman, and P.W. Kincade. 1993. CD44 and its interaction with the extracellular matrix. Adv. Immunol. 54:271-335.
11. Thomas, L., H.R. Byers, J. Vink, and I. Stamenkovic. 1992. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118: 971-977.
12. Miyake, K., K. Medina, S.-I. Hayashi, S. Ono, T. Hamaoka, and P.W. Kincade. 1990. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171:477-488.
13. Gunthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haubmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65: 13-24.
14. Sherman, L., J. Sleeman, P. Herrlich, and H. Ponta. 1994. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell Biol. 6:726-733.
15. Bartolazzi, A., R. Peach, A. Aruffo, and I. Stamenkovic. 1994. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 180:53-66.
16. Takahashi, K., I. Stamenkovic, M. Cutler, H. Saya, and K.K. Tanabe. 1995. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene. 11:2223-2232.
17. Zahalka, M.A., E. Okon, U. Gosslar, B. Holzmann, and D. Naor. 1995. Lymph node (but not spleen) invasion by murine lymphoma is both CD44-and hyaluronate-dependent. J. Immunol. 154:5345-5355.
18. Zhang, L., C.B. Underhill, and L. Chen. 1995. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 55:428-433.
19. Driessens, M.H.E., P.J.M. Stroeken, N.F.R. Erena, M.A. Van der Valk, E.A.M. Van Rijthoven, and E. Roos. 1995. Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity. J. Cell Biol. 131:1849-1855.
20. Lesley, J., Q. He, K. Miyake, A. Hamann, R. Hyman, and P.W. Kincade. 1992. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 175:257-266.
21. Murakami, S., K. Miyake, C.H. June, P.W. Kincade, and R.J. Hodes. 1990. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 145:3618-3627.
22. Lesley, J., N. Howes, A. Perschl, and R. Hyman. 1994. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 180:383-387.
23. Stamenkovic, I., A. Aruffo, M. Amiot, and B. Seed. 1991. The hematopoictic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO (Eur. Mol. Biol. Organ.) J. 10:343-348.
24. Bourguignon, L.Y., V.B. Lokeshwar, J. He, X. Chen, and G.J. Bourguignon. 1992. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol. Cell. Biol. 12:446-4471.
25. Perschl, A., J. Lesley, N. English, R. Hyman, and I.S. Trowbridge. 1995. Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J. Cell Sci. 108:1033-1041.
26. Tsukita, S., K. Oishi, N. Sato, J. Sagara, A. Kawai, and S. Tsukita. 1994. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:391-401.
27. Pure, E., R.L. Camp, D. Peritt, R.A. Panettieri, Jr., A.L. Lazaar, and S. Nayak. 1995. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 181:55-62.
28. Lesley, J., P.W. Kincade, and R. Hyman. 1993. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur. J. Immunol. 23:1902-1909.
29. Zheng, Z., S. Katoh, Q. He, K. Oritani, K. Miyake, J. Lesley, R. Hyman, A. Hamik, R.M.E. Parkhouse, A.G. Farr, and P.W. Kincade. 1995. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 130:485-495.
30. Katoh, S., Z. Zheng, K. Oritani, T. Shimozato, and P.W. Kincade. 1995. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182:419-429.
31. Lesley, J., N. English, A. Perschl, J. Gregoroff, and R. Hyman. 1995. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 182:431-437.
32. Bennett, K.L., B. Modrell, B. Greenfield, A. Bartolazzi, I. Stamenkovic, R. Peach, D.G. Jackson, F. Spring, and A. Aruffo. 1995. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol. 131:1623-1633.
33. Takahashi, K., I. Stamenkovic, M. Cutler, A. Dasgupta, and K.K. Tanabe. 1996. Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J. Biol. Chem. 271:9490-9496.
34. He, Q., J. Lesley, R. Hyman, K. Ishihara, and P.W. Kincade. 1992. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J. Cell Biol. 119:1711-1719.
35. Johnson, A., and K. Dorshkind. 1986. Stromal cells in myeloid and lymphoid long-term bone marrow cultures can support multiple hemopoietic lineages and modulate their production of hemopoietic growth factors. Blood. 68: 1348-1354.
36. Palacios, R., and M. Steinmetz. 1985. IL3-dependent mouse clones that express B-220 surface antigen contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell. 41:727-734.
37. Katoh, S., J.B. McCarthy, and P.W. Kincade. 1994. Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth. J. Immunol. 153:3440-3449.
38. 1 by a rat anti-stromal cell monoclonal antibody. Hybridoma. 13:409-416.
39. Do, K.-Y., S.-I. Do, and R.D. Cummings. 1997. Differential expression of LacdiNAc sequences (GalNAcβ1-4GlcNAc-R) in glycoproteins synthesized by Chinese hamster ovary and human 293 cells. Glycobiology. 7:183-194.
40. Wilkins, P.P., R.P. McEver, and R.D. Cummings. 1996. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. J. Biol. Chem. 271:18732-18742.
41. Varki, A. 1994. Metabolic radiolabeling of glycoconjugates. In Methods of Enzymology. W.J. Lennarz and G.W. Hart, editors. Academic Press, Inc., San Diego. 16-31.
42. Merkle, R.K., and R.D. Cummings. 1987. Lectin affinity chromatography of glycopeptides. In Methods of Enzymology. V. Ginsburg, editor. Academic Press, Inc., San Diego. 232-259.
43. Cummings, R.D. 1992. Synthesis of asparagine-linked oligosaccharides: pathways, genetics, and metabolic regulation. In Glycoconjugates. Composition, Structure and Function. H.J. Allen and E.C. Kisailus, editors. Marcel Dekker, Inc., New York. 333-360.
44. Schwarz, R.T., and R. Datema. 1982. Inhibition of the dolichol pathway of protein glycosylation. Methods Enzymol. 83:432-443.
45. Elbein, A.D. 1987. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu. Rev. Biochem. 56:497-534.
46. Kojima, N., M. Saito, and S. Tsuji. 1994. Role of cell surface O-linked oligosaccharide in adhesion of HL60 cells to fibronectin: regulation of integrin-dependent cell adhesion by O-linked oligosaccharide elongation. Exp. Cell Res. 214:537-542.
47. Sasaki, H., B. Bothrer, A. Dell, and M. Fukuda. 1987. Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J. Biol. Chem. 262:12059-12076.
48. Seguchi, T., R.K. Merkle, M. Ono, M. Kuwano, and R.D. Cummings. 1991. The dysfunctional LDL-receptor in a monensin-resistant mutant of Chinese hamster ovary cells lacks selected O-linked oligosaccharides. Arch. Biochem. Biophys. 284:245-256.
49. Rearick, J.I., A. Chapman, and S. Kornfeld. 1981. Glucose starvation alters lipid-linked oligosaccharide biosynthesis in Chinese hamster ovary cells. J. Biol. Chem. 256:6255-6261.
50. Fuhrmann, U., E. Bause, and H. Ploegh. 1985. Inhibitors of oligosaccharide processing. Biochem. Biophys. Acta. 825:95-110.
51. Lesley, J., and R. Hyman. 1992. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Enr. J. Immunol. 22:2719-2723.
52. Shtivelman, E., and J.M. Bishop. 1991. Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell. Biol. 11:5446-5453.
53. Turley, E.A., A.J. Belch, S. Poppema, and L.M. Pilarski. 1993. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood. 81:446-453.
54. McCourt, P.A.G., B. Ek, N. Forsberg, and S. Gustafson. 1994. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J. Biol. Chem. 269:30081-30084.
55. Yannariello-Brown, J., B. Zhou, and P.H. Weigel. 1997. Identification of a 175 kDa protein as the ligand-binding subunit of the rat liver sinusoidal endothelial cell hyaluronan receptor. Glycobiology. 7:15-21.
56. Jalkanen, S., M. Jalkanen, R. Bargatze, M. Tammi, and E.C. Butcher, 1988. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol. 141:1615-1623.
57. Brown, T.A., T. Bouchard, T. St. John, E. Wayner, and W.G. Carter. 1991. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol. 113:207-221.
58. Sutherland, D.R., K.M. Abdullah, P. Cyopick, and A. Mellors. 1992. Cleavage of the cell-surface O-sialoglycoproteins CD34, CD43, CD44, and CD45 by a novel glycoprotease from Pasteurella haemolytica. J. Immunol. 148: 1458-1464.
59. Lokeshwar, V.B., and L.Y. Bourguignon. 1991. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/ CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J. Biol. Chem. 266:17983-17989.
60. Datema, R., and R.T. Schwarz. 1978. Formation of 2-deoxyglucose-containing lipid-linked oligosaccharides. Interference with glycosylation of glycoproteins. Eur. J. Biochem. 90:505-516.
61. Jalkanen, S., and M. Jalkanen. 1992. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116:817-825.
62. Faassen, A.E., J.A. Schrager, D.J. Klein, T.R. Oegema, J.R. Couchman, and J.B. McCarthy. 1992. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J. Cell Biol. 116:521-531.
63. Brissett, N.C., and S.J. Perkins. 1996. The protein fold of the hyaluronate-binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C-type lectin superfamily. FEBS (Fed. Eur. Biochem. Soc.) Lett. 388:211-216.
64. Kohda, D., C.J. Morton, A.A. Parkar, H. Hatanaka, F.M. Inagaki, I.D. Campbell, and A.J. Day. 1996. Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell. 86:767-775.
65. Bartolazzi, A., A. Nocks, A. Aruffo, F. Spring, and I. Stamenkovic. 1996. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol. 132:1199-1208.
66. Toyama-Sorimachi, N., H. Sorimachi, Y. Tobita, F. Kitamura, H. Yagita, K. Suzuki, and M. Miyasaka. 1995. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J. Biol. Chem. 270:7437-7444.
67. Weber, G.F., S. Ashkar, M.J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science (Wash. DC). 271:509-512.
68. Naujokas, M.F., M. Morin, M.S. Anderson, M. Peterson, and J. Miller. 1993. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell. 74:257-268.
69. Isacke, C.M. 1994. The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. 107:2353-2359.
70. Guo, Y., J. Ma, J. Wang, X. Che, J. Narula, M. Bigby, M. Wu, and M.-S. Sy. 1994. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54:1561-1565.
71. Stark, N.J., and E.C. Heath. 1979. Glucose-dependent glycosylation of secretory glycoprotein in mouse myeloma cells. Arch. Biochem. Biophys. 192: 599-609.
72. Mueller-Klieser, W., and S. Walenta. 1993. Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem. J. 25:407-420.
73. Tamulevicius, P., and C. Streffer. 1995. Metabolic imaging in tumours by means of bioluminescence. Br. J. Cancer. 72:1102-1112.
74. Romarís, M., A. Bassols, and G. David. 1995. Effect of transforming growth factor-β1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican. Biochem. J. 310:73-81.
75. Levesque, M.C., and B.F. Haynes. 1996. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J. Immunol. 156:1557-1565.